New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
10:00 EDTIVN, CLH, CHTR, BMO, TFM, SKUL, PLCM, CCRN, COG, UCBI, HAE, BPI, BKE, SWY, OCR, CPA, SIRI, PRU, SD, UNP, TEVA, QSII, GTATOn The Fly: Analyst Upgrade Summary
Copa Holdings (CPA) upgraded to Buy from Neutral at UBS... Cross Country Healthcare (CCRN) upgraded to Buy from Neutral at Citigroup... GT Advanced (GTAT) upgraded to Outperform from Neutral at Credit Suisse... Omnicare (OCR) upgraded to Buy from Neutral at UBS... Polycom (PLCM) upgraded to Buy from Neutral at Citigroup... Quality Systems (QSII) upgraded to Market Perform from Underperform at FBR Capital... Safeway (SWY) upgraded to Neutral from Sell at UBS... Skullcandy (SKUL) upgraded to Outperform from Market Perform at Northland Securities... Teva (TEVA) upgraded to Overweight from Equal Weight at Barclays... The Buckle (BKE) upgraded to Neutral from Sell at Janney Capital... The Fresh Market (TFM) upgraded to Buy from Neutral at UBS... Union Pacific (UNP) upgraded to Outperform from Market Perform at Avondale... Bridgepoint Education (BPI) upgraded to Outperform at William Blair... Bank of Montreal (BMO) upgraded to Sector Performer from Underperformer at CIBC... SandRidge Energy (SD) upgraded to Overweight at Stephens citing turnaround progress... Haemonetics (HAE) upgraded to Buy from Neutral at Sidoti... Charter (CHTR) upgraded at Northland Securities... Prudential (PRU) upgraded to Buy from Neutral at BofA/Merrill... United Community Banks (UCBI) upgraded to Buy from Hold at Sandler O'Neill... Sirius XM (SIRI) upgraded at Macquarie... Clean Harbors (CLH) upgraded at Raymond James... Cabot Oil & Gas (COG) upgraded to Buy from Accumulate at KLR Group... Ivanhoe Mines (IVN) upgraded to Buy from Neutral at UBS.
News For CPA;CCRN;GTAT;OCR;PLCM;QSII;SWY;SKUL;TEVA;BKE;TFM;UNP;BPI;BMO;SD;HAE;CHTR;PRU;UCBI;CLH;SIRI;COG;IVN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
June 26, 2015
10:38 EDTTEVACourt revives lawsuit over GlaxoSmithKline Lamictal drug, Bloomberg reports
Subscribe for More Information
09:18 EDTSIRISirius XM discloses settlement agreement with various record companies
Subscribe for More Information
June 25, 2015
19:58 EDTCHTRCharter will not block, throttle net traffic
Subscribe for More Information
13:59 EDTTEVATeva initiated with a Hold at HSBC
Subscribe for More Information
12:52 EDTCHTRCharter to 'go further' than net neutrality rules in TWC merger, Variety reports
Subscribe for More Information
12:52 EDTTEVAEU to decide by July 29 on Mylan's bid for Perrigo, Reuters reports
Subscribe for More Information
08:05 EDTTEVATeva, Active Biotech say patient enrollment finalized for CONCERTO trial
Subscribe for More Information
June 24, 2015
14:51 EDTSIRISirius XM, Fox News announce partnership on new channel
Subscribe for More Information
08:04 EDTTEVATeva launches PainMatters.com to support ‘responsible pain management’
Subscribe for More Information
June 23, 2015
14:16 EDTTEVABMO Capital sees strong fundamentals in Perrigo regardless of Mylan deal
Shares of Perrigo (PRGO) are trading higher intraday after BMO Capital Markets initiated coverage of the stock with an Outperform rating. The research firm is bullish on the shares regardless of whether Mylan's bid for the company succeeds, saying Perrigo is well-positioned to ride momentum in reduced-price healthcare. WHAT'S NEW: BMO Capital Markets' David Maris initiated coverage of Perrigo with an Outperform rating and a $246 price target. Maris cited the company's 70%-plus market share in store- and private-label brands, as well as its roughly $1B annual sales in the generics space. The analyst believes Perrigo will see continued benefit from larger trends driving consumer-centric healthcare and the curtailing of medical costs. WHAT'S NOTABLE: BMO Capital Markets noted that two upcoming Tysabri-related events are not accounted for by the Street, giving rise to a "significant" undervaluing of the shares. Mylan (MYL) has submitted multiple unsolicited offers for Perrigo, and while the likelihood of the deal seems low given Perrigo's numerous rejections and Teva's (TEVA) 4.61% blocking stake in Mylan. BMO Capital remarked that a failed deal should see "limited downside" for Perrigo. There could certainly be near-term volatility if a Mylan agreement doesn't materialize, but the analyst was confident in the well-positioned company's ability to deliver on both earnings per share and cash flow. PRICE ACTION: Shares of Perrigo are up nearly 2% in afternoon trading. The company saw a nearly 25% leap following Mylan's initial offer on April 8, though it has since dipped from that high.
11:28 EDTSIRISirius XM management to meet with FBR Capital
Subscribe for More Information
10:40 EDTOCRCVS Health sees Omnicare transaction closing by end of year
Subscribe for More Information
08:54 EDTSKULSkullcandy weakness overdone, says DA Davidson
Subscribe for More Information
08:49 EDTTEVAMylan CFO to meet with Tel Aviv bourse head Wednesday, Reuters says
Subscribe for More Information
June 22, 2015
17:04 EDTPLCMOn The Fly: Top stock stories for Monday
Subscribe for More Information
10:00 EDTPLCMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:28 EDTHAEHaemonetics participates in a conference call with Benchmark
Conference call with Chief Technology Officer Dr. Jonathan White and Vice President of Global Diagnostics, Krista Thompson will be held on June 22 at 10 am hosted by Benchmark.
07:13 EDTBMOUBS to hold a conference
Subscribe for More Information
06:50 EDTPLCMPolycom downgraded to Underperform from Market Perform at William Blair
William Blair downgraded Polycom to Underperform saying its field-level discussions indicated the company's business has come under "increasing pressure" in the June quarter. Polycom is being hurt by weak video demand and increased competition, William Blair tells investors.
June 21, 2015
19:53 EDTTEVAMylan CEO says Teva's 4.61% stake may be 'illegal,' Bloomberg reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use